Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 60.19 0.64% 0.38
ANIP closed up 0.64 percent on Thursday, February 6, 2025, on 2.36 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
Earnings due: Feb 26
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Up Up

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Up 3 Days in a Row Strength 0.00%
Pocket Pivot Bullish Swing Setup 0.64%
Multiple of Ten Bearish Other 0.64%
Pocket Pivot Bullish Swing Setup 2.73%
20 DMA Support Bullish 3.94%
Doji - Bullish? Reversal 3.94%
Gapped Down Weakness 3.94%

   Recent Intraday Alerts

Alert Time
200 DMA Resistance about 9 hours ago
60 Minute Opening Range Breakout about 11 hours ago
Rose Above 200 DMA about 11 hours ago
Up 1% about 11 hours ago
10 DMA Support about 14 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ANI Pharmaceuticals, Inc. Description

ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Retail Outlets Pharmacology Suspension Manufacturing Facilities Contract Manufacturing Chloroarenes Contract Manufacturing Services Cough Estrogen Testosterone Antacid Antiemetics Laxatives Enema Metoclopramide Offers Contract Manufacturing Services Prolactin Releasers

Is ANIP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

Indicators

Indicator Value
52 Week High 70.81
52 Week Low 52.5
Average Volume 233,919
200-Day Moving Average 60.22
50-Day Moving Average 56.85
20-Day Moving Average 57.86
10-Day Moving Average 59.22
Average True Range 1.69
RSI (14) 62.12
ADX 23.63
+DI 30.19
-DI 14.96
Chandelier Exit (Long, 3 ATRs) 55.94
Chandelier Exit (Short, 3 ATRs) 57.79
Upper Bollinger Bands 61.82
Lower Bollinger Band 53.91
Percent B (%b) 0.79
BandWidth 13.67
MACD Line 0.93
MACD Signal Line 0.79
MACD Histogram 0.1424
Fundamentals Value
Market Cap 1.27 Billion
Num Shares 21 Million
EPS -0.47
Price-to-Earnings (P/E) Ratio -128.06
Price-to-Sales 2.21
Price-to-Book 2.98
PEG Ratio 1.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 63.15
Resistance 3 (R3) 63.09 62.04 62.65
Resistance 2 (R2) 62.04 61.29 62.07 62.49
Resistance 1 (R1) 61.12 60.83 61.58 61.18 62.32
Pivot Point 60.07 60.07 60.31 60.10 60.07
Support 1 (S1) 59.15 59.32 59.61 59.21 58.06
Support 2 (S2) 58.10 58.86 58.13 57.89
Support 3 (S3) 57.18 58.10 57.73
Support 4 (S4) 57.24